ATBECHDEDKESFR..GRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*J0009290-CORR014149460CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120250108W184deBibliographieenBibliographyfrBibliographieEP21725377.2202105132022121420230421enenenPCT/EP2020/06524420200602WO20200830320200602GB20201689066420200602US20201895020201201GB20201895520201201GB20201710867920201201US20201710893820201201US20210398120210322GB20211720858320210322USPCT/EP2021/06075020210423WO2025010820250220230322202312202411272024482024071620250108202502A61K 31/4045 20060101AFI20240412BHEP A61P 25/18 20060101ALI20240412BHEP A61P 25/22 20060101ALI20240412BHEP A61P 25/24 20060101ALI20240412BHEP A61P 25/30 20060101ALI20240412BHEP C07D 209/16 20060101ALI20240412BHEP A61K 9/16 20060101ALI20240412BHEP A61K 9/20 20060101ALI20240412BHEP A61K 9/48 20060101ALI20240412BHEP A61K 45/06 20060101ALI20240412BHEP A61P 25/00 20060101ALI20240412BHEP A61K 31/4045 20130101 LI20210803BHEP A61K2300/00 20130101 LI20210803BHEP A61P 25/00 20180101 LI20210616BHEP C07D 209/16 20130101 FI20210616BHEP A61K 9/2009 20130101 LA20210817BHEP A61K 9/2013 20130101 LA20210817BHEP A61K 9/2027 20130101 LA20210817BHEP A61K 9/2059 20130101 LA20210817BHEP A61K 9/485 20130101 LA20210817BHEP A61K 9/4858 20130101 LA20210817BHEP A61K 9/4866 20130101 LA20210817BHEP A61K 31/4045 20130101 LI20210709BHEP A61K 45/06 20130101 LI20210803BHEP A61P 25/18 20180101 LI20210709BHEP A61P 25/22 20180101 LI20210709BHEP A61P 25/24 20180101 LI20210709BHEP A61P 25/30 20180101 LI20210709BHEP deFESTE THERAPEUTISCHE DARREICHUNGSFORMENenTHERAPEUTIC SOLID DOSAGE FORMSfrFORMES GALÉNIQUES SOLIDES THÉRAPEUTIQUESWO-A1-2019/081764WO-A1-2020/245133SIMON D. BRANDT ET AL: "Microwave-accelerated synthesis of psychoactive deuterated N , N -dialkylated-[ [alpha] , [alpha] , [beta] , [beta] -d 4 ]-tryptamines", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, vol. 51, no. 14, 1 November 2008 (2008-11-01), GB, pages 423 - 429, XP055724013, ISSN: 0362-4803, DOI: 10.1002/jlcr.1557MORRIS ET AL.: "Indolealkylamine metabolism: Synthesis of deuterated indolealkylamines as metabolic probes", JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 33, no. 6, 1993, pages 455 - 465, XP009522345, DOI: 10.1002/jlcr.2580330603BEATON J M ET AL: "A comparison of the behavioral effects of proteo- and deutero-N, N-dimethyltryptamine", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, ELSEVIER, US, vol. 16, no. 5, 1 May 1982 (1982-05-01), pages 811 - 814, XP023806754, ISSN: 0091-3057, DOI: 10.1016/0091-3057(82)90240-424215587.720241126RANDS, PeterLondon EC2A 4BXGBBENWAY, TiffanieLondon EC2A 4BXGBJOEL, ZelahLondon EC2A 4BXGBLAYZELL, MarieLondon EC2A 4BXGBJAMES, EllenLondon EC2A 4BXGBCybin UK Ltd102032801SPH-P029WOEP50 Featherstone StreetLondon EC1Y 8RTGBPatent Boutique LLP10151206310A Printing House Yard Hackney RoadLondon E2 7PRGBALATBEBGCHCYCZDEDKEEESFIFRGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTREP202106279420210513enWO202124483120211209202149